Giancarlo Francese
Senior Program Officer, Global Health @Gates Foundation
Signup · Get unlimited contacts
WORK HISTORY
Senior Program Officer, Global Health @Gates Foundation
Seattle, WA, US
I design and guide end-to-end strategies that accelerate breakthrough health technologies from early discovery through regulatory submission and industrial scale-up, with a strong focus on anticipating future market, regulatory, and manufacturing inflection points.I lead high-level strategic engagements with global pharmaceutical leaders, multilateral institutions, investment banks, and investment funds across U.S, Europe, Middle East, and East Asia, structuring innovative partnerships and sustainable financing models that de-risk innovation, strengthen manufacturing resilience, and enable long-term system impact—particularly in global health.I lead the governance and deployment of a $180M+ global innovation and investment portfolio, spanning early scientific concepts through clinical development, industrialization, regulatory readiness, and post-submission phases. The portfolio focuses on translating next-generation healthcare technologies into scalable, capital-efficient platforms with strong execution and sustainability profiles.I advise on strategic investment and capital allocation decisions to improve cost efficiency, supply security, and scalability in LMICs, translating frontier science into durable, investable health infrastructure. I build and manage diversified portfolios of high-impact investments and grant instruments, designed to meet ambitious cost, quality, scalability, and delivery objectives while creating optionality for future public–private and commercial pathways.I lead the strategic identification and activation of AI-enabled partnerships supporting predictive R&D, diagnostics, and data-driven optimization of healthcare manufacturing and supply chains. Acting as a strategic interface between Program Strategy Teams, Foundation leadership, and external partners (Co-Chairs, CEOs, Board Members), I foster cross-sector collaboration and structure sustainable public–private partnerships to deliver transformative global health innovation.
EDUCATION
Università di Pavia
M.Sc. (Laurea) in Chemistry, Chemistry
Ecole Nationale Supérieure de Chimie de Montpellier
Erasmus, Chemistry
University of Bern
Ph.D., Chemisty
SKILLS
ABOUT GIANCARLO FRANCESE
Global healthcare and life-sciences executive with 20+ years of international leadership experience driving innovation strategy, platform development, and investment-aligned execution across pharmaceutical R&D, advanced drug delivery (small molecules, antibodies, siRNA, peptides), manufacturing technologies, and resilient global supply chains.Currently responsible for the governance and deployment of a $180M+ global innovation and investment portfolio, I specialize in translating frontier science into scalable, industrialized platforms through disciplined innovation governance, capital prioritization, and strategic external partnerships. I have co-created and helped structure Teva’s $5B+ Sustainability-Linked Bond, the largest of its kind globally at issuance and the first in the pharmaceutical sector to link both social and environmental performance targets directly to financing terms, demonstrating the integration of capital markets instruments with operational and sustainability strategy.I lead the strategic identification, activation, and governance of AI-enabled partnerships to advance predictive R&D, quality systems, diagnostics, remote monitoring, and data-driven optimization of manufacturing and supply chains at global scale. Structuring a North Africa–based Regional Pharmaceutical Logistics Hub, aligning regulatory reform, Public–Private Partnership frameworks, AI-driven logistics architecture, cost-efficiency modeling, and development finance engagement to advance a bankable, infrastructure-grade health platform.Recognized for shaping forward-looking strategies that anticipate technological, regulatory, and market inflection points, I translate innovation into scalable, investable, and capital-efficient platforms across the life-sciences ecosystem.Combining deep scientific expertise with strong strategic and financial judgment, I have led high-stakes initiatives with global pharmaceutical companies, governments, multilateral organizations, and investment institutions, designing capital-efficient development pathways and sustainability-linked investment structures.I have held senior leadership roles at Novartis, Teva Pharmaceuticals, and the Gates Foundation, working across the U.S, Europe, Africa, and Asia. I bring a strong governance mindset, disciplined risk assessment, and cross-sector perspective to help organizations build durable platforms and long-term value creation.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.